CCL2 and COVID-19: MCP-1, a pro-inflammatory chemokine well-known to be increased in COVID-19 patients [91,92,93,94,95], was also found to be increased in SARS-CoV-2-exposed HBMEC conditioned media, as detected by mini-proteome assays.